台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    77.8
  • 漲跌
    ▼1.1
  • 漲幅
    -1.39%
  • 成交量
    475
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中裕 (4147)籌碼相關-兆豐-公益 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-公益 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/132.178.4600.0077.802.11,8340.11%
2025/05/08578.4000.0079.1051,8620.27%
2025/05/07278.3500.0079.0021,8700.11%
2025/05/0600.001480.1480.20-141,873-0.75%
2025/04/28680.2000.0080.0061,8610.32%
2025/04/2400.00579.5279.60-51,879-0.27%
2025/04/11371.9300.0073.8032,3770.13%
2025/04/10473.4000.0073.4042,3720.17%
2025/04/09369.23567.6266.80-22,377-0.08%
2025/04/08171.4000.0071.3012,3310.04%
2025/04/0700.00079.2079.2002,2920.00%
2025/04/021.188.1700.0087.901.12,2940.05%
2025/03/31289.7000.0088.0022,2770.09%
2025/03/28194.6100.0093.8012,2570.04%
2025/03/271095.7300.0096.10102,2480.44%
2025/03/2600.00198.7098.10-12,230-0.04%
2025/03/24198.3000.0099.0012,1920.05%
2025/03/21197.7000.0096.4012,1490.05%
2025/03/1800.00191.7091.90-12,085-0.05%
2025/03/17193.2000.0091.9012,0770.05%
2025/03/1400.00192.3092.50-12,087-0.05%
2025/03/13194.4000.0091.6012,0990.05%
2025/03/12096.1000.0097.5002,0600.00%
2025/03/06197.00196.3094.3001,9570.00%
2025/03/0500.00296.9598.60-21,924-0.10%
2025/03/04192.4000.0095.5011,9040.05%
2025/02/271095.5000.0095.50101,8780.53%
2025/02/2500.001101.5099.30-11,856-0.05%
2025/02/241100.0000.0099.3011,7960.06%
2025/02/214100.655102.1698.90-11,727-0.06%
2025/02/20197.56498.3099.70-31,553-0.19%
2025/02/19194.8000.0095.2011,5100.07%
2025/02/18193.40194.7094.0001,4910.00%
2025/02/1722101.454107.1397.10181,4401.25%
2025/02/1400.00398.8798.90-31,226-0.24%
2025/02/1100.00190.3091.70-11,140-0.09%
2025/01/20182.80184.2084.2001,1360.00%
2025/01/17085.2000.0084.6001,1310.00%
2025/01/1300.00189.3089.90-11,132-0.09%
2025/01/09196.4000.0087.5011,0140.10%
2025/01/0800.005101.5097.20-5872-0.57%
2024/12/23183.4000.0082.9016120.16%
2024/12/0900.00290.4090.10-2600-0.33%
2024/12/0300.00285.8084.30-2529-0.38%
2024/11/2700.000.184.1083.60-0.1535-0.02%
2024/11/1800.00078.9078.7005340.00%
2024/10/3000.00182.0081.40-1601-0.17%
2024/10/2300.00181.0081.80-1570-0.18%
2024/10/16174.3000.0074.2016060.16%
2024/10/14174.0000.0074.0016140.16%
2024/09/27180.2000.0080.1016490.15%
2024/09/1800.00181.2081.40-1665-0.15%
2024/09/13179.4000.0079.3016720.15%
2024/09/0300.00184.0084.00-1751-0.13%
2024/07/3000.00182.6083.90-1737-0.14%
2024/07/23187.0000.0086.5017460.13%
2024/07/2200.00189.7087.10-1745-0.13%
2024/07/18188.4000.0088.4017090.14%
2024/07/1700.00187.2088.10-1713-0.14%
2024/07/03187.4000.0087.4019530.10%
2024/06/2600.00189.8089.50-11,123-0.09%
2024/06/2400.00888.2586.70-81,128-0.71%
2024/06/21189.0000.0088.9011,1210.09%
2024/06/1700.00291.9591.50-21,153-0.17%
2024/06/0700.00489.8890.10-41,167-0.34%
2024/06/03189.7000.0089.6011,3860.07%
2024/05/31188.2000.0090.1011,4200.07%
2024/05/3000.00489.3588.60-41,475-0.27%
2024/05/22288.50288.2588.5002,1000.00%
2024/05/21288.4000.0088.0022,1230.09%
2024/05/16285.9000.0086.9022,1890.09%
中裕首度與美國客戶簽訂CDMO合約 營運添動能Anue鉅亨-13天前
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-2025/04/09
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕 相關文章